Global Bioburden Testing Market is Expected to Grow at CAGR 12.5% From 2017 to 2024.
Data Bridge Market Research new Insight’s on “Global Bioburden Testing Market is projected to reach 907.4 million by 2024, from USD 452.6 million in 2016 growing at a CAGR of 9.1% during the forecast period of 2017 to 2024”.
The market is segmented By Test Type (Aerobic, Anaerobic, Fungi, Spore), By Product Type (Instruments (PCR, Automated Microbial Identification Systems, Microscopes, Others), Consumables (Kits & Strips, Reagents, Others), By Technology (Microbial Filter Method, Advanced Colorimetric Method, Plate Count Method, Rapid Testing), By Application (Raw Material Testing, In-Process Testing, Medical Device Testing, Pharmaceutical & Cosmetic Testing, Food and Beverage Testing), By End-User (Pharmaceutical, Biotechnology, Industrial, Food & Beverages), By Geography (North America, Europe, Asia-Pacific, South America and Middle East Asia) – Industry Trends and Forecast to 2024
The actual calculation year for the report in 2016, while the historic data is for 2015 and the forecast period is still 2024.
Global Bioburden Testing Market: Recent Developments
Bioburden testing is the method of calculating the load of microorganisms, in or on a medical instrument, raw material, packaged goods among others. The results from bioburden testing are used to determine the sterilization methods to be used while processing the material. Every measurement requires a definitive unit to quantify it; in bioburden testing the unit is CFU (Colony forming Units) per gram or per square centimeter.
Varying trends in the pharmaceutical and biotechnology industries, increasing medical device usage, market awareness and trend towards food safety, strong R&D investments in life science are the major factors contributing to the growth of global bioburden testing market. These technological advantage and cost effectiveness are the main driving factor for bioburden testing market in the forecast period 2017 to 2024.
On the other hand, the towering cost instruments and compound time consuming rigid standards which extend the approval process in some counties may delay the growth of this market. Emerging economies such as India and China present a range of opportunities for this market. Companies into bioburden testing market are adopting popular strategies approaches such as innovative product launches, acquisition and others in order of expansion of market.
Global Bioburden Testing Market Categories: Segmentation
The global Bioburden Testing Market is segmented on the basis of test type, product type, technology, application, end-user, and geography.
On the basis of test type the bioburden testing market is segmented into aerobic, anaerobic, fungi and spore count.
The bioburden testing market segment is further categorized on the basis of product type into instruments and consumable.
On the basis of technology microbial filter method, advanced colorimetric method and plate count method. The plate count method and membrane filtration method can be used to analyze the number of microbes in sample.The sample is passing through a filter with a pore size of 0.45 micrometers or less. Oldest methods for bioburden testing plate count method, however is not used frequently on a great scale commercial basis due to its time consuming procedure. Advanced colorimetric method is at the moment the most capable and widely used bioburden testing technology. The gathering of colorimeter and computational capabilities has enabled advanced colorimetric methods to deliver swift results of quantifying bioburden
Global Bioburden Testing Market: Geographic Segmentation
Based on geography the market is segmented into 7 geographical regions, North America, Latin America, Europe, Asia-Pacific, Japan and Middle East and Africa. The geographical regions are further segmented into major countries such as U.S. Canada,Brazil, Argentina, Nordics,Benelux, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Australia and New Zealand, Brazil, India, Russia, South Africa and many others.
Global Bioburden Testing Market: Company Share Analysis
The Global Bioburden Testing Market report contains an in-depth profiling of the key market players, along with the recent developments (innovative product launches, agreements, joint ventures, business and alliance) and strategies adopted by them to continue and build up their positions in the market. Some of the major players operating in this market are Pacific Bio labs, SGS S.A., WuXi PharmaTech Inc., Becton, Dickinson and Company, Merck & Co., Inc., Charles River Laboratories International Inc., North American Science Associates, Inc. (NAMSA), Nelson Laboratories, Inc., Dynatec Labs, and ATS Labs, Inc. among others.
The global bioburden testing market is highly fragmented with various companies operating in local regions. The major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes company share data for different geographies including Global, North America, Europe and APAC.
Other Market Insights:
Global Point-of-Care Testing (POCT) Market, latest insights by Data Bridge Market Research states that the market is growing at CAGR of 9.5% in the forecast period 2017 to 2024, expected to reach USD 38.2 Billion by 2024.
APAC Point-of-Care Testing (POCT) Market, latest insights by Data Bridge Market Research states that the market is growing at CAGR of 14.6% in the forecast period 2017 to 2024, expected to reach USD 11.5 Billion by 2024.